Michael Cherny
Stock Analyst at Leerink Partners
(4.13)
# 1,610
Out of 4,649 analysts
555
Total ratings
57.1%
Success rate
5.6%
Average return
Main Sectors:
Stocks Rated by Michael Cherny
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CAH Cardinal Health | Maintained: Buy | $240 → $292 | $235.17 | +24.17% | 39 | Aug 11, 2026 | |
| GDRX GoodRx Holdings | Maintained: Buy | $5 | $3.73 | +34.05% | 24 | Aug 6, 2026 | |
| MEDP Medpace Holdings | Maintained: Hold | $490 → $620 | $578.50 | +7.17% | 7 | Jul 23, 2026 | |
| PGNY Progyny | Maintained: Buy | $38 | $26.28 | +44.60% | 36 | Jul 22, 2026 | |
| ALGN Align Technology | Reiterated: Buy | $230 | $181.31 | +26.85% | 20 | Jun 30, 2026 | |
| CERT Certara | Reiterated: Buy | $13 → $8 | $8.00 | - | 16 | Jun 16, 2026 | |
| XRAY DENTSPLY SIRONA | Maintained: Hold | n/a | $11.59 | - | 34 | Jun 12, 2026 | |
| MDLN Medline | Maintained: Buy | $56 → $52 | $35.74 | +45.50% | 4 | Jun 12, 2026 | |
| ICLR ICON Public Limited Company | Maintained: Hold | $125 → $145 | $163.15 | -11.12% | 17 | May 28, 2026 | |
| DOCS Doximity | Rated: Buy | $79 → $25 | $24.80 | +0.81% | 14 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $28.15 | - | 32 | Apr 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $98 | $97.16 | +0.86% | 66 | Mar 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $87 | $89.77 | -3.09% | 31 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $35 | $28.07 | +24.69% | 24 | Feb 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $43 | $24.78 | +73.53% | 1 | Feb 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $232 → $256 | $236.66 | +8.17% | 16 | Dec 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $203 → $210 | $234.40 | -10.41% | 18 | Oct 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $5 → $6 | $0.9509 | +530.98% | 21 | Oct 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $323 → $342 | $318.13 | +7.50% | 14 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $349 → $361 | $313.82 | +15.03% | 37 | Oct 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $869.00 | - | 45 | Oct 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $7.5 | $6.81 | n/a | 19 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $542 | $505.75 | n/a | 1 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $146.26 | n/a | 1 | Sep 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.55 | n/a | 1 | Jul 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 | $4.90 | n/a | 16 | Jun 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $7.5 | $12.45 | n/a | 1 | Jan 5, 2022 |
Cardinal Health
Aug 11, 2026
Maintained: Buy
Price Target: $240 → $292
Current: $235.17
Upside: +24.17%
GoodRx Holdings
Aug 6, 2026
Maintained: Buy
Price Target: $5
Current: $3.73
Upside: +34.05%
Medpace Holdings
Jul 23, 2026
Maintained: Hold
Price Target: $490 → $620
Current: $578.50
Upside: +7.17%
Progyny
Jul 22, 2026
Maintained: Buy
Price Target: $38
Current: $26.28
Upside: +44.60%
Align Technology
Jun 30, 2026
Reiterated: Buy
Price Target: $230
Current: $181.31
Upside: +26.85%
Certara
Jun 16, 2026
Reiterated: Buy
Price Target: $13 → $8
Current: $8.00
Upside: -
DENTSPLY SIRONA
Jun 12, 2026
Maintained: Hold
Price Target: n/a
Current: $11.59
Upside: -
Medline
Jun 12, 2026
Maintained: Buy
Price Target: $56 → $52
Current: $35.74
Upside: +45.50%
ICON Public Limited Company
May 28, 2026
Maintained: Hold
Price Target: $125 → $145
Current: $163.15
Upside: -11.12%
Doximity
May 15, 2026
Rated: Buy
Price Target: $79 → $25
Current: $24.80
Upside: +0.81%
Apr 16, 2026
Maintained: Hold
Price Target: n/a
Current: $28.15
Upside: -
Mar 24, 2026
Reiterated: Buy
Price Target: $98
Current: $97.16
Upside: +0.86%
Feb 24, 2026
Reiterated: Hold
Price Target: $87
Current: $89.77
Upside: -3.09%
Feb 6, 2026
Upgraded: Buy
Price Target: $35
Current: $28.07
Upside: +24.69%
Feb 2, 2026
Initiated Coverage: Buy
Price Target: $43
Current: $24.78
Upside: +73.53%
Dec 14, 2025
Maintained: Buy
Price Target: $232 → $256
Current: $236.66
Upside: +8.17%
Oct 22, 2025
Reiterated: Buy
Price Target: $203 → $210
Current: $234.40
Upside: -10.41%
Oct 9, 2025
Rated: Hold
Price Target: $5 → $6
Current: $0.9509
Upside: +530.98%
Oct 8, 2025
Reiterated: Buy
Price Target: $323 → $342
Current: $318.13
Upside: +7.50%
Oct 6, 2025
Maintained: Buy
Price Target: $349 → $361
Current: $313.82
Upside: +15.03%
Oct 6, 2025
Maintained: Buy
Price Target: n/a
Current: $869.00
Upside: -
Jul 30, 2025
Reiterated: Hold
Price Target: $7.5
Current: $6.81
Upside: n/a
Dec 20, 2024
Reiterated: Buy
Price Target: $542
Current: $505.75
Upside: n/a
Sep 4, 2024
Maintained: Hold
Price Target: n/a
Current: $146.26
Upside: n/a
Jul 8, 2024
Reiterated: Buy
Price Target: n/a
Current: $1.55
Upside: n/a
Jun 14, 2023
Maintained: Buy
Price Target: $22
Current: $4.90
Upside: n/a
Jan 5, 2022
Maintained: Hold
Price Target: $7.5
Current: $12.45
Upside: n/a